Exelixis to lay off 130 employees, shut down Pennsylvania site in post-pandemic downsizing
27th August 2025 Uncategorised 0Mere months after its cancer blockbuster hopeful topped Bayer’s Stivarga in a phase 3 trial, Exelixis is conducting a reorganization that will see the oncology company’s Pennsylvania site wind down and 130 employees laid off, a company spokesperson confirmed to Fierce Biotech.
More: Exelixis to lay off 130 employees, shut down Pennsylvania site in post-pandemic downsizing
Source: fierce